CRSP
CRISPR Therapeutics AGData as of 2026 Q2 (06-30) · 13F snapshot
Summary
CRISPR Therapeutics AG (CRSP) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$564.56M; the largest are Cathie Wood, Ken Griffin, Izzy Englander. 4 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 1 added, 3 trimmed. 4 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Cooling
Common-stock holders44 also report options
Congress trades4
Price$54.09vs quarter-end-0.83%
Sectors3
This quarter's moves
Top holderNew0
Added1
Trimmed / sold3
Cathie WoodCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Cathie WoodTrim
Value $516.00M3.4% of portfolio9,460,9392026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Cathie Wood | $516.00M | 3.4% | Trim |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $15.82M— of portfolio290,1002026 Q2
Value $13.97M— of portfolio256,2002026 Q2
Value $3.15M— of portfolio57,7002026 Q2
Value $1.39M— of portfolio25,5002026 Q2
Value $1.24M— of portfolio22,7002026 Q2
Value $959.9K— of portfolio17,6002026 Q2
Value $872.6K— of portfolio16,0002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinPUT | $15.82M | — | — |
| Ken GriffinCALL | $13.97M | — | — |
| Izzy EnglanderCALL | $3.15M | — | — |
| Steven CohenCALL | $1.39M | — | — |
| Paul Tudor JonesCALL | $1.24M | — | — |
| Steven CohenPUT | $959.9K | — | — |
| Paul Tudor JonesPUT | $872.6K | — | — |
ARK ETF holdings
Cathie Wood · dailyARK total shares held · drag to inspect
2026-09-29holds 8,975,226
- ARKGweight in fund5.21%$113.48M
- ARKKweight in fund4.35%$371.99M
ARK publishes full ETF holdings daily (SEC Rule 6c-11). Line shows ARK's total shares held over time (not price); markers are buy/sell days. Derived from public CSVs — research only, not investment advice.
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.